Australia markets close in 5 hours 51 minutes

NextCell Pharma AB (65G.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.1500-0.0045 (-2.91%)
At close: 11:38AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/08/2023
31/08/2022
31/08/2021
31/08/2020
Total revenue
12,450
10,113
5,589
3,912
3,565
Cost of revenue
10,951
10,998
8,723
18,440
13,938
Gross profit
1,499
-884.834
-3,134
-14,528
-10,373
Operating expenses
Selling general and administrative
-
-
-
8,501
7,173
Total operating expenses
42,299
40,117
31,890
10,294
7,329
Operating income or loss
-40,800
-41,002
-35,024
-24,821
-17,702
Interest expense
0.932
2.812
13.528
7.573
8.838
Income before tax
-39,374
-39,812
-34,554
-24,557
-17,681
Income tax expense
0
0
0
0
0
Income from continuing operations
-39,374
-39,812
-34,554
-24,557
-17,681
Net income
-39,374
-39,812
-35,554
-24,557
-17,681
Net income available to common shareholders
-39,374
-39,812
-35,554
-24,557
-17,681
Basic EPS
-1.16
-1.16
-1.03
-0.71
-0.68
Diluted EPS
-1.16
-1.16
-1.03
-0.71
-0.68
Basic average shares
34,380
34,380
34,380
34,380
26,099
Diluted average shares
34,380
34,380
34,380
34,380
26,099